Denali Therapeutics Inc.
Clinical trials sponsored by Denali Therapeutics Inc., explained in plain language.
-
New Alzheimer's drug enters early human testing
Disease control Recruiting nowThis study tests an experimental drug called DNL628 in people with early Alzheimer's disease. The main goal is to check if the drug is safe and how the body processes it. About 68 participants will receive either the drug or a placebo. This is an early-stage trial, so it focuses …
Phase: PHASE1 • Sponsor: Denali Therapeutics Inc. • Aim: Disease control
Last updated May 17, 2026 03:56 UTC
-
New drug targets genetic Parkinson's in early trial
Disease control Recruiting nowThis study tests an experimental drug called BIIB122 in 50 people with a specific genetic form of Parkinson's disease (LRRK2-PD). The goal is to check the drug's safety and how it affects certain markers in the body over 12 weeks. Participants are randomly assigned to receive eit…
Phase: PHASE2 • Sponsor: Denali Therapeutics Inc. • Aim: Disease control
Last updated May 17, 2026 03:54 UTC